NVLNF stock forecast
Our latest prediction for Novelion Therapeutics, Inc.'s stock price was made on the Dec. 12, 2019 when the stock price was at 0.68$.
In the short term (2weeks), NVLNF's stock price should underperform the market by -2.60%. During that period the price should oscillate between -11.22% and +14.90%.
In the medium term (3months), NVLNF's stock price should underperform the market by -11.05%. During that period the price should oscillate between -26.97% and +41.14%.Get email alerts
About Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. engages in the development and commercialization of pharmaceuitical products. It focuses in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and is headquartered in Vancouver, Canada.
At the moment the company generates 135M USD in revenues.
On its last earning announcement, the company reported a loss of -5.67$ per share.
The book value per share is -6.06$
Three months stock forecastDec. 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|